JMP Securities Downgrades Anadys Pharmaceuticals (ANDS) to Market Perform
Tweet
Share
E-mailGet Alerts ANDS Hot Sheet
Price: $3.70 --0%
Rating Summary:
0 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 3 | New: 12
Rating Summary:
0 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 3 | New: 12
Join SI Premium – FREE
JMP Securities downgraded Anadys Pharmaceuticals (NASDAQ: ANDS) from Outperform to Market Perform with a new price target of $3.00.
For more ratings news on Anadys Pharmaceuticals click here and for the rating history of Anadys Pharmaceuticals click here.
Shares of Anadys Pharmaceuticals closed at $0.86 yesterday.
For more ratings news on Anadys Pharmaceuticals click here and for the rating history of Anadys Pharmaceuticals click here.
Shares of Anadys Pharmaceuticals closed at $0.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades Haivision Systems (HAI:CN) (HAIVF) to Hold
- Arete Downgrades Uber Inc. (UBER) to Neutral
- Morgan Stanley Downgrades Novo Nordisk (NVO) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
